Safety of PARP inhibitors as maintenance therapy in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of PARP inhibitors as maintenance therapy in ovarian cancer

Published:2023-09-14 Issue:10 Volume:22 Page:897-908
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Cecere Sabrina Chiara¹,Casartelli Chiara²,Forte Miriam³,Pignata Sandro¹,Pisano Carmela¹

Affiliation:

1. Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy

2. Medical Oncology Unit, University Hospital of Parma, Parma, Italy

3. Department of Precision Medicine, Division of Medical Oncology, University of Campania Luigi Vanvitelli, Naples, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2254699

Reference77 articles.

1. Epidemiology of ovarian cancer

2. Cancer statistics, 2015

3. Non-Epithelial Ovarian Cancers: How Much Do We Really Know?

4. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

5. Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer;Journal of Translational Medicine;2024-08-21

2. Genetic landscape of homologous recombination repair and practical outcomes of PARPi therapy in ovarian cancer management;Therapeutic Advances in Medical Oncology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3